Contemporary outcomes and mortality risks of Ebstein anomaly: A single-center experience in Thailand

Congenital Heart Disease
Varisara PornprasertchaiJarupim Soongswang

Abstract

The increasing number of patients with Ebstein anomaly (EA) surviving into adulthood implies improvements in the treatments for the complex lesion. We revisited the clinical outcomes of patients with EA to demonstrate their "real world" survival. To identify the survival and predictors of mortality in patients with EA who underwent medical or surgical management in the present era. All patients who had EA with atrioventricular concordance between 1994 and 2016 were retrospectively reviewed. Baseline characteristics, initial echocardiographic findings, treatments, and outcomes were explored. The survival analysis was performed at the end of 2017. A multivariate analysis was used to assess mortality risks. A total of 153 patients (25.4 ± 20.4 years, 60% female) were analyzed. Of these, 89 patients had been diagnosed with EA in childhood. During the follow-up [median time of 5.2 years (3 days-23.5 years)], 32 patients (20.9%) died due to major cardiac adverse events. The overall survival at 1, 5, and 10 years were 89%, 82.2%, and 79%, respectively. Of the total 153 patients, 64 patients underwent at least one surgical intervention [median age of 17 years (1 day-64.4 years)]. The survival at 1, 5, and 10 years were 87.5%, 82.4%, an...Continue Reading

References

Dec 1, 1985·Journal of the American College of Cardiology·J K OhG K Danielson
Jan 1, 1994·Journal of the American College of Cardiology·D S CelermajerJ E Deanfield
Sep 27, 2000·The Thoracic and Cardiovascular Surgeon·J Hebe
Jan 18, 2007·Circulation·Christine H Attenhofer JostGordon K Danielson
May 6, 2008·The Journal of Thoracic and Cardiovascular Surgery·Morgan L BrownUNKNOWN Mayo Clinic Congenital Heart Center
Aug 31, 2010·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Committee for Practice Guidelines (CPG)
Mar 1, 2011·The Journal of Thoracic and Cardiovascular Surgery·Umar S BostonChristopher J Knott-Craig
Mar 16, 2012·Cardiology in the Young·Angela OxeniusEmanuela R Valsangiacomo Buechel
Apr 22, 2015·Circulation·Ami B BhattUNKNOWN American Heart Association Council on Clinical Cardiology
Apr 26, 2015·Heart, Lung & Circulation·Queenie LuuDavid S Celermajer
Aug 26, 2016·Congenital Heart Disease·Lianne M GeerdinkLivia Kapusta
Oct 7, 2016·Journal of Korean Medical Science·Hyung Yoon KimSeung Woo Park
Nov 28, 2017·The Annals of Thoracic Surgery·Kimberly A HolstPatrick W O'Leary

❮ Previous
Next ❯

Citations

Jan 10, 2020·European Heart Journal. Quality of Care & Clinical Outcomes·Filip EckerströmZacharias Mandalenakis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.